Efficacy of chemically cross-linked antigens for acellular pertussis vaccine

By Watanabe M.   Nagai M.   Funaishi K.   Endoh M.  

Vaccine, Vol. 19, Iss. 9, 2000-12 ,pp. : 1199-1203

Elsevier

Access to resources Recommend Favorite

The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in respiratory mouse model

By Heininger U.   Stehr K.   Cherry J.D.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1255-1255

Elsevier

Access to resources Recommend Favorite

The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model

By Willems R.J.L.   Kamerbeek J.   Geuijen C.A.W.   Top J.   Gielen H.   Gaastra W.   Mooi F.R.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 410-416

Elsevier

Access to resources Recommend Favorite

Efficacy of pertussis components in an acellular vaccine, as assessed in a murine model of respiratory infection and a murine intracerebral challenge model

By Watanabe M.   Komatsu E.   Abe K.   Iyama S.   Sato T.   Nagai M.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1429-1434

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules

By Multicenter Working Group   Giammanco G.   Moiraghi A.   Zotti C.   Pignato S.   Li Volti S.   Giammanco A.   Soncini R.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 722-726

Elsevier

Access to resources Recommend Favorite